NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

No, we’re both critiquing the ability of the regulators to keep up with technology and the ability of market makers to basically manage pricing rather than responding to market demand or lack thereof. It does not necessarily prevent companies from ultimately becoming successful, but yes, the market making has been corrupted when there is little basis for setting the price and they can do so on their own, pre commercialization. The issue is especially true and bad with pre-commercialized microcap biotechs. And as a society, we will maybe become most aware of the issue in this segment. Regulators will then, with the substantial and required help of Congress, which is typically the most recalcitrant part of the system, work to address the newer challenges. I expect they will need to start getting software.